Caballero, Arth, JR. B.
HRN: 18-00-94 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/08/2022
CEFUROXIME 1.5GM (VIAL)
06/08/2022
06/14/2022
IV
1.5gm
Q8
Hypovolemic Shock Sec To Age; T/dengue Fever, T/c Typhoid Fever; T/c Uti; T/c Sol
Waiting Final Action
Indication: Empiric Type of Infection: Urinary TractCentral Nervous System Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes